The increasing use of this biomarker in association with several PSA derivatives, such as free to total PSA ratio (%fPSA), PSA density (PSAD), and PSA velocity, has led to frequent detection of small, well differentiated, low-risk PCa without significant decrease in mortality[3]. This evidence concerns the gene KLK3 and posterior cortical atrophy.